Home  >  Products  >  PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 ) Blocking Peptide (the C terminal of PFKFB1)(100ug)
PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 ) Blocking Peptide (the C terminal of PFKFB1)(100ug)

PFKFB1 (6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 ) Blocking Peptide (the C terminal of PFKFB1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-PFKFB1 Antibody (ARP61879_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61879
Size: 100ug
Weight: 52kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: This gene encodes a member of the family of bifunctional 6-phosphofructo-2-kinase:fructose-2,6-biphosphatase enzymes. The enzyme forms a homodimer that catalyzes both the synthesis and degradation of fructose-2,6-biphosphate using independent catalytic domains. Fructose-2,6-biphosphate is an activator of the glycolysis pathway and an inhibitor of the gluconeogenesis pathway. Consequently, regulating fructose-2,6-biphosphate levels through the activity of this enzyme is thought to regulate glucose homeostasis.
Alternative names: F6PK; HL2K; MGC116715; MGC116717; PFRX
See Full Product Listings >